India Molecular Diagnostics Market Size, Share & Trends Report

India Molecular Diagnostics Market (2025 - 2033) Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables), By Test Location, By Technology, By Platform, By Application, By End Use, And Segment Forecasts

Market Segmentation

  • India Molecular Diagnostics Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Instruments
    • Reagents and Consumables
    • Others
  • India Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2021 - 2033)
    • Point of Care
    • Self-Test or OTC
    • Central Laboratories
  • India Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2021 - 2033)
    • Polymerase Chain Reaction (PCR)
      • Multiplex PCR
      • Real-Time PCR
      • Open PCR
    • Others
  • India Molecular Diagnostics Platform Outlook (Revenue, USD Million, 2021 - 2033)
    • Sample-to-answer
    • High-throughput Closed Systems
    • Open PCR/LDT Platforms
  • India Molecular Diagnostics Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Gastrointestinal Infections
      • Enteric Bacterial
        • Salmonella
        • Shigella
        • Campylobacter
        • E. Coli
        • Others
      • Enteric Viral
        • Norovirus
        • Rotavirus
        • Adenovirus
        • Astrovirus
        • Sapovirus
      • Enteric Parasitic
        • Giardia Lamblia
        • Cryptosporidium spp.
        • Entamoeba Histolytica
    • Respiratory Infections
      • Viral Respiratory Infections
        • Influenza A & B
        • SARS-CoV-2
        • RSV
        • Human Metapneumovirus
        • Parainfluenza
        • Adenovirus
        • Rhinovirus / Enterovirus
        • Others
      • Bacterial Respiratory Infections
        • Mycobacterium Tuberculosis
        • Bordetella Pertussis
        • Mycoplasma Pneumoniae
        • Chlamydophila Pneumoniae
        • Others
    • Healthcare-Associated Infections
      • MRSA
      • Clostridium Difficile
      • Carbapenemase-Producing Organisms (CPO)
      • Others
    • Sexually Transmitted Infections & Women’s Health
      • HIV
      • Neisseria Gonorrhoeae
      • Hepatitis B (HBV)
      • Hepatitis C (HCV)
      • Trichomonas Vaginalis
      • Mycoplasma Genitalium
      • HSV
      • HPV
      • Group B Streptococcus (GBS)
      • Chlamydia Trachomatis
      • Syphilis
      • Others
    • Others
  • India Molecular Diagnostics End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Academic & Research Institutes
    • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2021 to 2033
  • Market estimates and forecast for product segments up to 2033
  • Regional market size and forecast for product segments up to 2033
  • Market estimates and forecast for application segments up to 2033
  • Regional market size and forecast for application segments up to 2033
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation